Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12042559 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Jaydeep Vagashiya, Navnit H. Shah, Dipen Desai, Wantanee Phuapradit +3 more | 2024-07-23 |
| 11318091 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Jaydeep Vaghashiya, Navnit H. Shah, Dipen Desai, Wantanee Phuapradit +3 more | 2022-05-03 |
| 11007145 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Jaydeep Vaghashiya, Navnit H. Shah, Dipen Desai, Wantanee Phuapradit +3 more | 2021-05-18 |
| 10960001 | Opioid agonist / antagonist combination dosage forms | Navnit H. Shah, Wantanee Phuapradit, Dipen Desai, Siva Ram Kiran Vaka, Chanchal Patel +2 more | 2021-03-30 |
| 10918597 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Ashish Chatterji, Navnit H. Shah, Wantanee Phuapradit, Dipen Desai +1 more | 2021-02-16 |
| 10857098 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Jaydeep Vaghashiya, Navnit H. Shah, Dipen Desai, Wantanee Phuapradit +3 more | 2020-12-08 |
| 10744131 | Abuse-resistant drug formulations | Siva Ram Kiran Vaka, Ashish Chatterji, Dipen Desai, Wantanee Phuapradit, Navnit H. Shah | 2020-08-18 |
| 10695296 | Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient | Navnit H. Shah, Ashish Chatterji, Helen Usansky, Louis Denis, Niranjan Rao +1 more | 2020-06-30 |
| 10034854 | Pharmaceutical composition with improved bioavailability | Steve Lomuscio, Hua Ma, Michael Allen Matchett, Navnit H. Shah, Yu Zhang | 2018-07-31 |
| 9663517 | Compositions and uses thereof | Dipen Desai, Ralph Diodone, Zenaida O. Go, Prabha N. Ibrahim, Raman Iyer +7 more | 2017-05-30 |
| 9447089 | Compositions and uses thereof | Dipen Desai, Ralph Diodone, Zenaida O. Go, Prabha N. Ibrahim, Raman Iyer +7 more | 2016-09-20 |
| 9427427 | Pharmaceutical composition with improved bioavailability | Steve Lomuscio, Hua Ma, Michael Allen Matchett, Navnit H. Shah, Yu Zhang | 2016-08-30 |
| 8222230 | Pharmaceutical compositions with superior product performance and patient compliance | Ashish Chatterji, Dipen Desai, Navnit H. Shah | 2012-07-17 |
| 6492530 | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability | Antonio A. Albano, Wantanee Phuapradit, Navnit H. Shah | 2002-12-10 |
| 6486329 | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability | Antonio A. Albano, Wantanee Phuapradit, Navnit H. Shah | 2002-11-26 |
| 6482847 | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability | Antonio A. Albano, Wantanee Phuapradit, Navnit H. Shah | 2002-11-19 |
| 6469179 | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability | Antonio A. Albano, Wantanee Phuapradit, Navnit H. Shah | 2002-10-22 |
| 6469180 | Amorphous form of cell inhibitor having improved solubility and bioavailability | Antonio A. Albano, Wantanee Phuapradit, Navnit H. Shah | 2002-10-22 |
| 6350786 | Stable complexes of poorly soluble compounds in ionic polymers | Antonio A. Albano, Wantanee Phuapradit, Navnit H. Shah | 2002-02-26 |